1. Home
  2. TNK vs SLS Comparison

TNK vs SLS Comparison

Compare TNK & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Tankers Ltd.

TNK

Teekay Tankers Ltd.

HOLD

Current Price

$99.52

Market Cap

2.5B

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$11.50

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNK
SLS
Founded
2007
2012
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
TNK
SLS
Price
$99.52
$11.50
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
★ $96.80
$32.50
AVG Volume (30 Days)
354.5K
★ 5.0M
Earning Date
11-06-2026
11-11-2026
Dividend Yield
★ 1.05%
N/A
EPS Growth
N/A
★ 50.00
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.17
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.05
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$50.94
$1.39
52 Week High
$110.65
$15.88

Technical Indicators

Market Signals
Indicator
TNK
SLS
Relative Strength Index (RSI) 53.35 48.42
Support Level $71.28 $10.78
Resistance Level $103.16 $12.62
Average True Range (ATR) 3.61 0.85
MACD -1.03 0.05
Stochastic Oscillator 37.85 58.58

Price Performance

Historical Comparison
TNK
SLS

About TNK Teekay Tankers Ltd.

Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: